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Deconstructing gelsol in: identifying sites that mimic or alter 
binding to actin and p hosphoinositides 
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Gelsolin is involved in cytoskeletal remodeling as it can 
fragment and guide reassembly of actin networks. Recent 
advances in defining the structure of gelsolin identified 
functionally important sites. These structural insights 
could lead to the design of small molecule analogs to 
enhance, inhibit or mimic the functions of gelsolin. 
Address: Experimental Medicine Division, Brigham and Women’s 
Hospital, 221 Longwood Avenue, Boston MA 02115, USA. 
Correspondence: Paul A Janmey 
E-mail: janmey@calvin.bwh.harvard.edu 
Chemistry & Biology April 1998,5:R81 -R85 
http://biomednet.com/elecref/10745521005R0081 
0 Current Biology Ltd ISSN 1074-5521 
Introduction 
Mutational analyses and studies of cell function have 
placed the actin-binding protein gelsolin in several clini- 
cally important settings, and the recently elucidated gel- 
solin structure [1,2] indicates sites on the protein that are 
potential targets for designing therapeutic agents. Gelsolin 
is an 84-87 kDa single polypeptide closely related to actin- 
binding proteins expressed in a wide variety of organisms 
(Figure 1). Mammalian gelsolin is expressed as both an 
intracellular (84 kDa) and secreted (87 kDa) protein by 
alternative splicing of a single gene [3]. In v&o, gelsolin 
has multiple effects on monomeric and polymeric actin 
Figure 1 
that suggest gelsolin functions in the cell to fluidize the 
cortical actin cytoskeleton, and to allow selective growth of 
filaments at sites where gelsolin is inactivated [4]. 
The functions of gelsolin in modulating the actin cytoskele- 
ton and some of its potential regulatory elements are shown 
in Figure 2. Gelsolin can bind two actin monomers to form 
nuclei to seed polymer growth. It also binds tightly to the 
fast growing end of actin filaments (F-actin) to prevent their 
growth and can bind at random to the actin filament and 
sever it. Many of these functions are activated in vitm by 
greater than micromolar concentrations of Caz+ or pH < 6, 
and inactivated by inositol phospholipids. Actin, calcium 
ions and phosphoinositides are the most extensively charac- 
terized cellular ligands for gelsolin, although binding to 
tropomyosin, phospholipase C-y (PLC-)I), phosphatidyl- 
inositol 3-kinase (PI 3-kinase) and phospholipase D (PLD) 
[S] have also been reported. In the cytoplasm, gelsolin may 
function by regulating the actin-based cytoskeleton [6] or 
by altering phosphoinositide turnover [7]. Ligands and reg- 
ulators of gelsolin are summarized in Table 1. 
The viability of gelsolin-null animals shows that any 
essential function of gelsolin can be performed by other 
factors, although the animals do have prolonged bleeding 
times, caused by altered platelet activation, and an 
impaired inflammatory response [B]. The sluggish cell 
activation in viva is consistent with a relationship between 
Gelsolin family members are widely expressed 
in eukaryotes. Individual species can express 
several gelsolin family members that can be 
restricted to specific cell types and 
developmental stages or co-expressed in the 
same cell type. The presence of gelsolin family 
members in plants, animals and unicellular 
organisms, indicated that the gelsolin family 
probably originated with the earliest 
eukaryotes. The names of gelsolin-related 
proteins are highlighted in red, and the 
organisms in which they are found are in black. 
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Actin binding and regulatory events during 
gelsolin-mediated cytoskeletal remodeling. 
Gelsolin (light red) is activated either by Ca*+ 
or H+ (pH < 7) to reveal actin-binding sites, or 
by proteases that cleave inhibitory domains to 
release active protein fragments (solid red) 
that interact with both monomeric or polymeric 
actin (blue). Polyphosphoinositides (green) 
phosphorylated either at the 3’ or 4’ position of 
the inositol ring inactivate gelsolin and expose 
the barbed end of the actin filament. 
experimentally altered gelsolin expression and cell motil- 
ity in vitro [6,9] and the placement of gelsolin downstream 
of rat in signaling for cytoskeletal changes [lo]. 
Gelsolin and disease 
Extracellular gelsolin is thought to function as part of a 
scavenging system involved in clearing actin released from 
cells into the blood upon injury or trauma [ 111. The exoge- 
nous administration of gelsolin could, potentially, soften 
pathologically stiff materials such as cystic fibrosis sputum 
or actin-containing blood clots. An amyloid disease, 
Finnish familial amyloidosis (FAF), characterized by 
cranial neuropathy and cornea1 lattice dystrophy, is caused 
by a point mutation in gelsolin. The mutation of 
Aspl87+Asn allows a single intracellular proteolytic event 
as the protein is targeted for secretion, allowing a further 
cut in the blood plasma to form an amyloidogenic fragment 
(see [ 121 for a recent reference). 
Intracellular gelsolin is a prominent target of caspase 3, 
suggesting gelsolin is involved in apoptosis, although in 
different contexts gelsolin can either promote [13] or 
inhibit [14] the onset of cell death. Neurons from mice 
lacking gelsolin are also more susceptible to excitotoxic 
cell death caused by increased influx of calcium through 
N-methyl D-aspartate (NMDA) receptors and voltage- 
dependent calcium channels [15]. 
In some types of human cancers decreased gelsolin 
expression correlates with cell transformation. A relation- 
ship between gelsolin expression and human cancers was 
proposed by Chaponnier and Gabbiani [16] on the basis 
of the absence of detectable gelsolin immunoreactivity in 
epithelial cells of breast carcinoma. Gelsolin is among the 
most prominently downregulated proteins in transformed 
Table 1 
Ligands and modulators of gelsolin. 
Ligand Function 
G-actin Binds to domains 1 and 4 to nucleate 
actin assembly 
F-actin Severs filaments and blocks the barbed end 
Ca*+ Binds at multiple sites to stimulate activity 
lnositol lipids Bind to domains 1 and 2 to prevent actin 
binding; preferential binding to Pl(3,4)P2; 
gelsolin-PIP3 complex isolated from osteoclasts 
PH Activates in absence of Ca*+ 
Caspase 3 Cleaves to activate severing 
Fibrin/fibronectin Possible concentration in clots 
ATP ADP-actin binds faster to gelsolin than 
ATP-actin; possible direct binding to gelsolin 
Tropomyosin Direct binding in vitro; in conjunction with 
caldesmon inhibits severing and allows 
reannealing of filaments 
Phospholipase C-y Inhibits activity; thrombin activation dissociates 
gelsolin-PLC complex in platelets 
Phospholipase C-8 Gelsolin-derived peptide stimulates activity 
Phospholipase D Stimulates activity 
PI 3-kinase Stimulates activity 
c-Src Phosphorylates gelsolin/PIP2 
rat Dissociates gelsolin/actin in cell extracts 
DNase Activates DNase/actin 
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human fibroblasts and epithelial cells, breast cancers in 
several species, bladder carcinoma and in late-stage, non- 
small cell lung cancers (see [17] for a recent reference). 
Reversion of the transformed phenotype of ras-trans- 
formed cells is accomplished by the overexpression of a 
His321 mutant form of gelsolin that has different effects 
to wild-type gelsolin on both actin and phospholipase 
function in vitro and appears to have tumor-suppressive 
activity [18]. Reversion to a more spread morphology with 
enhanced stress fiber formation by the Src-like kinase 
inhibitor radicicol was also accompanied by strong expres- 
sion of gelsolin [19], a finding that may relate to the 
observation that gelsolin is phosphorylated by c-Src in a 
phosphatidylinositol 4,5-bisphosphate (PIPZ)-dependent 
manner in a&o [ZO]. 
Gelsolin structure 
Recent elucidation of the tertiary structure of gelsolin by 
Burtnick et al. [Z] and of a complex of actin with a gelsolin 
fragment by McLaughlin et al. [l] provides insight into 
how this multifunctional protein interacts with actin and 
suggests sites where competing ligands may be targeted to 
alter selectively some of these functions for possible thera- 
peutic benefits in thrombolytic or inflammatory disorders. 
Sequence analysis suggests that gelsolin consists of six 
similar domains, and the domains are evident in the crystal 
structure. Biochemical analyses of proteolytic fragments 
and expressed protein truncates demonstrate that domains 
1 and 4 can bind actin monomers with high affinity, 
domain 2 is necessary for binding to the sides of filaments, 
and truncation of the carboxy-terminal residues of domain 
6 causes a loss of calcium sensitivity (see [Zl] for recent 
references). Domains 1 and 2 contain the minimal residues 
necessary for actin filament severing and regions within 
domains 2-6 are necessary for nucleation activity. Local- 
ization of domains necessary for the generation of a high 
affinity actin filament cap is more complicated. Constructs 
containing domain 2 of gelsolin strongly inhibit depoly- 
merization but not elongation from the barbed end of the 
actin filament, whereas both amino-terminal and carboxy- 
terminal truncates prevent monomer addition to filaments. 
Regulatory sites for Ca*+ and inositol lipids 
Gelsolin requires micromolar concentrations of calcium to 
interact with actin. Analysis of the calcium sensitivity of 
gelsolin truncates demonstrates that domain 6 is necessary 
for normal calcium regulation. As illustrated in Figure 3, a 
carboxy-terminal truncate lacking the residues beyond 
amino acid 732, (green in Figure 3) is no longer Ca2+ 
dependent, but retains all actin-binding functions present 
in the intact protein. Part of the carboxyl terminus of 
domain 6 (residues beyond 738) forms a helix that contacts 
the actin-binding helix in domain 2 (blue), but the 
carboxy-terminal helix can be removed without loss of 
Ca2+ sensitivity. This result demonstrates that although 
the carboxy-terminal helix may be involved in calcium 
Figure 3 
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Structure of gelsolin with functional and regulatory domains. The amino 
terminal amino acid is highlighted in purple. The actin-binding helix of 
domain 1 is yellow, the actin-binding helix of domain 2 is cyan, the PPI- 
binding peptides are identified in dark blue (amino acids 135-l 42) and 
red (amino acids 150-l 69) and the carboxy-terminal sequences 
necessary for calcium regulation are green. The space-filling model 
shows the region required for calcium regulation of severing. 
regulation of gelsolin function, it is not functioning alone. 
This finding is consistent with many studies indicating 
that gelsolin has two or possibly more calcium-binding 
sites involved in regulating activity [Z]. 
Polyphosphoinositides (PPI), especially products of the PI 
3-kinase pathway, are potent inhibitors of gelsolin activity, 
but gelsolin also alters phosphoinositide turnover in vtio 
and selectively affects inositol lipid remodeling in vitro, 
activating PI 3-kinase and PLD, and inhibiting PLC-y and 
the erythrocyte PIP kinase. Gelsolin could modulate PPI 
metabolism either by competing with the enzymes of PPI 
synthesis and degradation, or by generating specific 
domains of lipids necessary for normal enzyme function. 
Two sequences implicated in phosphoinositide binding are 
at the junction between domains 1 and 2 (Figure 3). 
Residues 135-142 at the end of domain 1 and the residues 
160-169 at the beginning of domain 2 of gelsolin have been 
identified as key components of gelsolin-phosphoinositide 
interface. The primary structures of these two PIPZ- 
binding site are similar to sites in other proteins such as 
PLC-p, PLC-y, and P-adrenergic receptor kinase [23]. As 
shown in Figure 3, these two domains are closely aligned, 
extended structures in the gelsolin crystal. In solution, PPIs 
induce a coil-helix transition in a peptide encompassing 
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Figure 4 
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Regions of interest in the gelsolin structure. These four orientations 
highlight various alterations in gelsolin structure or sequence, and 
differ in orientation by a 90” rotation around the Z-axis. For reference, 
the amino-terminal amino acid is purple. The region of proteolysis by 
caspase 3 is green. The cysteine residues involved in the disulfide 
bond are yellow and Asp187, which is mutated in Finnish type 
amyloidosis, is blue. Red identifies the histidine mutated to proline in 
revertants of ras-transformed cells. 
the PPI-binding sequence in domain 2 [24], suggesting that 
the effects of PPIs on gelsolin may involve a similar change 
in secondary structure that would alter or obscure nearby 
actin-binding sites. 
Possibilities for modulating or enhancing gelsolin function 
Inhibiting gelsolin 
Actin-filament severing is postulated to be a key function 
of gelsolin for initiating some types of cell protrusion such 
as membrane ruffling, and this activity requires gelsolin 
domains 1 and 2. As gelsolin minus platelets and neu- 
trophils are functional but activate more slowly than 
normal cells, targeting the sites on gelsolin necessary for 
function could provide a means to reduce inflammation or 
decrease pathological platelet activation. Many of the con- 
tacts present in the complex of gelsolin domain 1 and actin 
involve the long helix including residues loo-113 of gel- 
solin [l] (Figure 3, yellow) and include the sequence 
Leu-Asp-Asp-Tyr-Leu (LDDYL), a sequence found in 
many actin-binding proteins. Peptide sequences derived 
from domain 1 of gelsolin alter actin polymerization i vitro 
[ZS]. Presumably these peptides compete with gelsolin 
and other actin-binding proteins for actin, and are unlikely 
to be selective antagonists for gelsolin. Agents that bind to 
the helix in domain 1 of gelsolin and prevent interactions 
with actin may be expected to interfere more selectively 
with gelsolin’s severing and monomer-binding activities. 
Similarly, the helix within domain 2 is postulated to target 
gelsolin to the side of the actin filament but the helix is 
not absolutely necessary for gelsolin’s severing activity, as 
a construct consisting of domain 1 and the first ten amino 
acids of domain 2 (gelsolin l-160) can also sever F-actin. 
The construct has much slower severing kinetics than the 
full length molecule or truncates including domains 1-3, 
however. Domain 2 of gelsolin is necessary for both sever- 
ing and nucleating activities, and agents that interfere 
with its binding to the actin filament would be expected 
to be strong inhibitors of gelsolin-actin interactions. 
Activating gelsolin 
In some contexts, activating rather than inhibiting gel- 
solin may be physiologically beneficial. Intracellular gel- 
solin is normally inhibited from severing F-actin until 
activated locally by Caz+, or perhaps by low pH. As the 
actin-binding sites themselves are not directly Ca2+- 
dependent, however, severing and other functions can be 
activated by proteolytic cleavage of the inhibitory ele- 
ments. Gelsolin is a major substrate for the cell-death- 
promoting protease caspase-3, and cells that lack gelsolin 
are more resistant to apoptotic stimulation than control 
cells. Caspase-3 cleaves gelsolin approximately in half to 
generate a severing competent, but calcium-insensitive 
fragment that may initiate the cytoskeletal changes 
accompanying apoptosis. As illustrated in Figure 4, this 
caspase-sensitive site is part of an unstructured region of 
the molecule that extends from the rest of the compact 
crystal and presumably is readily available to the caspase 
in solution. Similar activation of gelsolin may be achieved 
by interfering with the domain 6-domain 2 inhibitory 
interaction and so has the potential for selective destabi- 
lization of the cytoskeleton in defective cells. 
Altering protein folding 
The mutation causing FAF (Asp187+Asn) is adjacent to 
a cysteine residue forming a disulfide bond between two 
elements of the p sheet in domain 2 of plasma gelsolin 
(Figure 4). Expression of the mutant protein causes the 
inappropriate intracellular proteolysis of plasma gelsolin 
during its transport. A second proteolytic event in the 
plasma generates the peptide containing residues 
173-243 of plasma gelsolin, that eventually forms the 
amyloid. Loss of the disulfide bond in recombinant 
plasma gelsolin also predisposes gelsolin to cleave at a 
similar site [26]. Stabilizing the p strands near the muta- 
tion and disulfide sites long enough to allow secretion 
may therefore prevent the pair of cleavage steps that form 
the amyloidogenic peptide. 
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Phosphoinositide-binding peptides 
Agents that target the PPI-binding sites of gelsolin may 
either enhance or inhibit gelsolin’s cellular function, by 
enhancing the dissociation of gelsolin from the inhibitory 
PPIs, or by preventing PPI-mediated dissociation of gel- 
solin from actin. The PPI-binding peptides themselves 
may also have functions that mimic those of gelsolin. Evi- 
dence of the effects of a gelsolin-related PIP&binding 
peptide on actin assembly in a cellular context are pro- 
vided by recent studies of the peptide’s ability to suppress 
PIPSdependent actin assembly and vesicle motility in a 
Xenopw oocyte extract [27] and its inhibition of platelet 
contractile function in platelet-rich plasma clots [B]. 
As the structural changes associated with gelsolin activa- 
tion begin to emerge, more surfaces where ligands may 
be designed to interfere with or mimic specific activities 
will be identified. Already, the elucidation of the site of 
caspase cleavage on a loop exposed on the gelsolin 
surface and the location of the FAF mutation very near a 
disulfide bond critical for stabilizing gelsolin identify 
regions where cellular gelsolin function can be selectively 
altered. More structural targets are likely to arise as both 
the chemistry and cellular function of this versatile 
protein are explored further. 
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